Uncategorized

Learn about a few of the many ways AI tools are helping to transform healthcare — and how they benefit physicians and patients along the way.

  Los también conocidos como levantadores hidráulicos de válvula o taqués de válvula hidráulica, son piezas que forman parte de los componentes esenciales en el tren de válvulas de cualquier motor de un vehículo de combustión int …

To safeguard M&A activity, CISOs and security teams must have a seat at the table to implement proper IT visibility.

  La administración remota de sistemas, como un servicio externalizado, ha ganado una gran importancia en el panorama empresarial actual, especialmente entre las grandes empresas, donde las infraestructuras pueden llegar a ser realmente complejas y su gestión requiere de expert …

Nxera Pharma Co., Ltd. is pleased to announce the launch of its new company name, having received approval at the 34th Ordinary General Meeting of Shareholders held on 27 March 2024.

BioArctic AB’s partner Eisai announced that Eisai has submitted a supplemental Biologics License Application for monthly lecanemab-irmb intravenous maintenance dosing to the U.S. Food and Drug Administration.

April kicks off with three FDA target action dates, including one that could potentially set the stage to move CAR-T therapies into earlier lines of treatment.

While disease-modifying therapies largely steal the spotlight in Alzheimer’s drug development, several companies are working to solve this less-discussed but disruptive facet of the illness.

With several recent approvals in the space and more on the horizon, BioSpace looks at some of the key decisions and their larger significance both for patients and science.

Now in Phase III with its small molecule orforglipron, Eli Lilly is leading the oral GLP-1 race against Novo Nordisk, Pfizer, Roche and others.